Zobrazeno 1 - 10
of 12
pro vyhledávání: '"therapeutic use, Antipsychotic Agents"'
Autor:
Daniel Pérez-Rodríguez, Maria Aránzazu Penedo, Tania Rivera-Baltanás, Tonatiuh Peña-Centeno, Susanne Burkhardt, Andre Fischer, José M. Prieto-González, José Manuel Olivares, Hugo López-Fernández, Roberto Carlos Agís-Balboa
Publikováno v:
International journal of molecular sciences 24(3), 1891 (2023). doi:10.3390/ijms24031891 special issue: "Identifying the Molecular Mechanisms of Psychiatric Disorders to Define New Therapeutic Targets"
International Journal of Molecular Sciences; Volume 24; Issue 3; Pages: 1891
International Journal of Molecular Sciences; Volume 24; Issue 3; Pages: 1891
Schizophrenia (SZ) is a serious mental disorder that is typically treated with antipsychotic medication. Treatment-resistant schizophrenia (TRS) is the condition where symptoms remain after pharmacological intervention, resulting in long-lasting func
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ba69f450dfc8ade13645a629f6878d
https://doi.org/10.3390/ijms24031891
https://doi.org/10.3390/ijms24031891
Autor:
Charles Timäus, Miriam Meiser, Borwin Bandelow, Kirsten R. Engel, Anne M. Paschke, Jens Wiltfang, Dirk Wedekind
Publikováno v:
BMC Psychiatry
BMC psychiatry 19(1), 393 (2019). doi:10.1186/s12888-019-2377-z
BMC Psychiatry, Vol 19, Iss 1, Pp 1-11 (2019)
BMC psychiatry 19(1), 393 (2019). doi:10.1186/s12888-019-2377-z
BMC Psychiatry, Vol 19, Iss 1, Pp 1-11 (2019)
Background The purpose of this study was to assess the pharmacological treatment strategies of inpatients with borderline personality disorder between 2008 and 2012. Additionally, we compared pharmacotherapy during this period to a previous one (1996
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::42a78061701cce6443605f503fd97954
https://pubmed.ncbi.nlm.nih.gov/31830934
https://pubmed.ncbi.nlm.nih.gov/31830934
Autor:
Schmidt, Stefanie J, Hurlemann, René, Wiesner, Pia-Sophie, Klosterkötter, Joachim, Ruhrmann, Stephan, Group, ESPRIT-B1, Bechdolf, A., Brockhaus-Dumke, A., Hirjak, D., Fallgatter, A., Frieling, H., Janssen, B., Schultz, Johannes, Jessen, F., Kambeitz, J., Koutsouleris, N., Leopold, K., Schäfer, C., Schultze-Lutter, F., Striepens, N., Vernaleken, I., Walter, H., Wildgruber, D., Wasserthal, Sven, Kloss, Christian, Maier, Wolfgang, Meyer-Lindenberg, Andreas, Hellmich, Martin, Muthesius-Digón, Ana, Pantel, Tanja
Publikováno v:
Early intervention in psychiatry 13(6), 1404-1415 (2019). doi:10.1111/eip.12781
AIM Meta-analyses indicate positive effects of both antipsychotic and cognitive-behavioural interventions in subjects clinically at high risk (CHR) for psychosis in terms of a delay or prevention of psychotic disorders. However, these effects have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea688489eb46fe301ba1bb347bc4d2d
https://pubmed.ncbi.nlm.nih.gov/30784233
https://pubmed.ncbi.nlm.nih.gov/30784233
Autor:
Nico Bunzeck, Franziska Knolle, Azucena Justicia, Emrah Düzel, Anna O. Ermakova, Graham K. Murray, Paul C. Fletcher
Publikováno v:
Translational Psychiatry 8(1), 196 (2018). doi:10.1038/s41398-018-0250-3
Translational Psychiatry, Vol 8, Iss 1, Pp 1-13 (2018)
Translational Psychiatry, Vol 8, Iss 1, Pp 1-13 (2018)
Abnormal salience processing has been suggested to contribute to the formation of positive psychotic symptoms in schizophrenia and related conditions. Previous research utilising reward learning or anticipation paradigms has demonstrated cortical and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e1991395145ecac57c92f5c0be55b9
https://pub.dzne.de/record/140253
https://pub.dzne.de/record/140253
Autor:
Tilly Eichler, Johannes Hertel, Jochen René Thyrian, Wolfgang Hoffmann, Bernhard Michalowsky, Stefan J. Teipel, Ingo Kilimann, Diana Wucherer
Publikováno v:
Journal of Alzheimer's disease 43(4), 1303-1311 (2014). doi:10.3233/JAD-141554
The present study is the first to analyze primary data about the use of antipsychotic drugs among community dwelling people with dementia in German primary care.To determine (1) prevalence of antipsychotic drug treatment in German primary care patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7293219ce134ae54ef1f3d41da92de53
https://doi.org/10.3233/jad-141554
https://doi.org/10.3233/jad-141554
Autor:
Wolfgang Hoffmann, Jochen René Thyrian, Sebastian Laufs, Tilly Eichler, Bernhard Michalowsky, Diana Wucherer, Steffen Fleßa, Johannes Hertel
Publikováno v:
Journal of Alzheimer's disease 42(3), 949-958 (2014). doi:10.3233/JAD-140804
Background: Results of cost-of-illness studies in dementia have shown a considerable divergence in costs of medication for persons with dementia. However, detailed economic analyses of medication costs for community-dwelling persons with dementia are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3931aab2de2ab4b85ae524c248895695
https://doi.org/10.3233/jad-140804
https://doi.org/10.3233/jad-140804
Autor:
Julia Strathmann, John D. Elsworth, Robert H. Roth, Claes Wahlestedt, David Willoughby, Matthew S Lawrence, Thomas A. Lanz, Brooke H. Miller, Paul J. Kenny, Li Xi, Shibing Deng, Robin J. Kleiman, Dieter Edbauer, Zane Zeier
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America 109(8), 3125-3130 (2012). doi:10.1073/pnas.1113793109
Schizophrenia is characterized by affective, cognitive, neuromorphological, and molecular abnormalities that may have a neurodevelopmental origin. MicroRNAs (miRNAs) are small noncoding RNA sequences critical to neurodevelopment and adult neuronal pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6dfe8e4b2fbf333367e5ade41fc7160
https://doi.org/10.1073/pnas.1113793109
https://doi.org/10.1073/pnas.1113793109
Autor:
Carsten Culmsee, Bastian Hengerer, Anderson de Andrade, Matthias Höllerhage, Tobias Hildebrandt, Günter U. Höglinger, Wolfgang H. Oertel, Joachim N. Goebel, Amalia M. Dolga
Publikováno v:
Neurobiology of aging 35(7), 1700-1711 (2014). doi:10.1016/j.neurobiolaging.2014.01.027
Parkinson's disease (PD) is the most frequent neurodegenerative movement disorder. Presently, there is no causal therapy available to slow down or halt disease progression. The presynaptic protein alpha-synuclein aggregates to form intraneuronal Lewy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ccc30d9961bcc0365778dcb18dba8c5
Publikováno v:
Current pharmaceutical design 19(36), 6416-6425 (2013). doi:10.2174/1381612811319360003
Introduction of diffusion tensor imaging (DTI) in 1980 and its advancement in the last three decades offered the possibility to visualize and quantify changes in white matter. DTI allows the evaluation of the structural integrity in complex neurodege
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b13802fd3832e81d398e068438c559
https://pub.dzne.de/record/137059
https://pub.dzne.de/record/137059
Autor:
Jahns, Karl-Peter, Kilimann, Ingo, Ritter, Christoph A, Hoffmann, Wolfgang, Teipel, Stefan J, Fiß, Thomas
Publikováno v:
Medizinische Monatsschrift für Pharmazeuten 35(3), 95-103 (2012).
Due to demographic changes we are faced with several challenges as an increasing prevalence of dementia patients. We report on a medication review of a patient with Alzheimer's disease as well as Lewy body dementia. The intake of risperidone was inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d8a9b9893d180da11ec6b7597a832fef
https://pubmed.ncbi.nlm.nih.gov/22452126
https://pubmed.ncbi.nlm.nih.gov/22452126